Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:37 pm Purchase | 2021-12-31 | 13G | INOZYME PHARMA INC INZY | Flynn James E | 2,344,786 9.910% | 1,194,487 (+103.84%) | Filing History |
| 2022-02-11 4:22 pm Sale | 2021-12-31 | 13G | ITAMAR MED LTD - SPONSORED ADR ITMR | Flynn James E | 0 0.000% | -23,814,090 (Position Closed) | Filing History |
| 2022-02-11 4:21 pm Sale | 2021-12-31 | 13G | PUMA BIOTECHNOLOGY INC PBYI | Flynn James E | 0 0.000% | -3,959,741 (Position Closed) | Filing History |
| 2022-02-11 4:21 pm Sale | 2021-12-31 | 13G | SPRUCE BIOSCIENCES INC SPRB | Flynn James E | 0 0.000% | -18,929 (Position Closed) | Filing History |
| 2022-02-11 4:20 pm Purchase | 2021-12-31 | 13G | XERIS BIOPHARMA HLDGS INC XERS | Flynn James E | 5,882,353 4.500% | 5,882,353 (New Position) | Filing History |
| 2022-02-11 4:19 pm Sale | 2021-12-31 | 13G | SURROZEN INC SRZN | Flynn James E | 11,111 0.470% | -22,222 (-66.67%) | Filing History |
| 2022-02-11 4:19 pm Sale | 2021-12-31 | 13G | BEYOND AIR INC XAIR | Flynn James E | 41,667 3.030% | -1,176 (-2.74%) | Filing History |
| 2022-02-11 4:18 pm Sale | 2021-12-31 | 13G | WAVE LIFE SCIENCES LTD WVE | Flynn James E | 552,690 0.940% | -3,357,740 (-85.87%) | Filing History |
| 2022-02-11 4:17 pm Sale | 2021-12-31 | 13G | MERIDIAN BIOSCIENCE INC VIVO | Flynn James E | 1,125,083 2.590% | -1,035,917 (-47.94%) | Filing History |
| 2022-02-11 4:17 pm Sale | 2021-12-31 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | Flynn James E | 1,867,467 3.710% | -853,736 (-31.37%) | Filing History |
| 2022-02-11 4:16 pm Purchase | 2021-12-31 | 13G | GENEDX HLDGS CORP WGS | Flynn James E | 423,237 5.790% | 3,586 (+0.85%) | Filing History |
| 2022-02-11 4:15 pm Sale | 2021-12-31 | 13G | TERNS PHARMACEUTICALS INC TERN | Flynn James E | 2,345,959 9.280% | -36,074 (-1.51%) | Filing History |
| 2022-02-11 4:14 pm Sale | 2021-12-31 | 13G | XILIO THERAPEUTICS INC XLO | Flynn James E | 153,861 7.840% | -9,564 (-5.85%) | Filing History |
| 2022-02-11 4:14 pm Purchase | 2021-12-31 | 13G | NUVALENT INC NUVL | Flynn James E | 24,776,278 45.140% | 24,776,278 (New Position) | Filing History |
| 2022-02-11 4:13 pm Purchase | 2021-12-31 | 13G | PROFOUND MED CORP COM PROF | Flynn James E | 1,713,797 8.250% | 673,376 (+64.72%) | Filing History |
| 2022-02-11 4:13 pm Unchanged | 2021-12-31 | 13G | IGNYTE ACQUISITION CORP COM IGNY | Flynn James E | 725,000 9.950% | 0 (Unchanged) | Filing History |
| 2022-02-11 4:12 pm Unchanged | 2021-12-31 | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | Flynn James E | 694,942 5.540% | 0 (Unchanged) | Filing History |
| 2022-02-11 4:12 pm Sale | 2021-12-31 | 13G | APRIA INC APR | Flynn James E | 1,655,795 4.670% | -775,622 (-31.90%) | Filing History |
| 2022-02-11 4:12 pm Purchase | 2021-12-31 | 13G | ORGANOGENESIS HLDGS INC CLASS ORGO | Flynn James E | 8,456,876 6.570% | 762,513 (+9.91%) | Filing History |
| 2022-02-11 4:11 pm Sale | 2021-12-31 | 13G | BIODELIVERY SCIENCES INTL INC BDSI | Flynn James E | 29,204 0.030% | -9,500,796 (-99.69%) | Filing History |